Pharmaceutical Investing Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer 10 January
Pharmaceutical Investing Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts 18 December 2025
Pharmaceutical Investing PADCEV Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility 17 December 2025
